Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Aug 3, 2018 at 10:40 AM EDT

Eli Lilly to Spin Off Elanco in IPO

Animal health company Elanco Animal Health has filed with the SEC regarding its initial public offering.

Chris Lange | Aug 2, 2018 at 9:40 AM EDT

Teva Just Can’t Seem to Get Earnings Right

Teva shares stumbled after it released its most recent quarterly results before the markets opened on Thursday.

Chris Lange | Jul 31, 2018 at 9:15 AM EDT

Pfizer Gets the Script Flipped on It in Q2

Pfizer released better-than-expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 30, 2018 at 10:40 AM EDT

What to Expect When Pfizer Reports Tuesday

Pfizer is scheduled to release its second-quarter financial results before the markets open on Tuesday.

Chris Lange | Jul 30, 2018 at 10:05 AM EDT

Why Sienna Biopharmaceuticals Shares Are Stumbling

Sienna Biopharmaceuticals shares pulled back on Monday after the company announced less than favorable results from a couple of its…

Chris Lange | Jul 30, 2018 at 9:50 AM EDT

Why RedHill Is Monday’s Big Biopharma Winner

RedHill Biopharma shares made a solid gain early on Monday after the firm announced positive results from its late-stage trial…

Chris Lange | Jul 27, 2018 at 11:20 AM EDT

Why AbbVie Earnings Were Not Enough for Investors

AbbVie released a better-than-expected quarterly report early on Friday, but shares retreated afterward.

Chris Lange | Jul 27, 2018 at 10:40 AM EDT

Merck Underwhelms Despite Beating Earnings

Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.

Chris Lange | Jul 26, 2018 at 10:40 AM EDT

Should Celgene Be Getting More Love?

Celgene released better-than-expected quarterly results and updated guidance before the markets opened on Thursday.

Chris Lange | Jul 25, 2018 at 4:19 PM EDT

Gilead Earnings Beat Not Enough For Investors

Gilead reported its most recent quarterly results after the markets closed on Wednesday. The major biotech posted $1.91 in earnings…

Chris Lange | Jul 25, 2018 at 12:40 PM EDT

What to Expect When Gilead Reports

Gilead is scheduled to release its second-quarter financial results after the markets close on Wednesday, and analyst expectations are low.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 25, 2018 at 7:10 AM EDT

Major Biotechs See a Rising Tide of Short Interest

The July 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 24, 2018 at 10:55 AM EDT

Does Biogen Deserve More Credit for Q2 Earnings?

Biogen released better-than-expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 23, 2018 at 1:45 PM EDT

Why Haliburton Is Monday’s Big Earnings Loser

Haliburton released solid second-quarter financial results before the markets opened on Monday, but there are growing concerns.

1 … 124 125 126 127 128 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Eli Lilly to Spin Off Elanco in IPO

Teva Just Can’t Seem to Get Earnings Right

Pfizer Gets the Script Flipped on It in Q2

What to Expect When Pfizer Reports Tuesday

Why Sienna Biopharmaceuticals Shares Are Stumbling

Why RedHill Is Monday’s Big Biopharma Winner

Why AbbVie Earnings Were Not Enough for Investors

Merck Underwhelms Despite Beating Earnings

Should Celgene Be Getting More Love?

Gilead Earnings Beat Not Enough For Investors

What to Expect When Gilead Reports

Major Pharma Stocks Scare Off Short Sellers

Major Biotechs See a Rising Tide of Short Interest

Does Biogen Deserve More Credit for Q2 Earnings?

Why Haliburton Is Monday’s Big Earnings Loser

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Health and Healthcare Articles

All Health and Healthcare Articles

Eli Lilly to Spin Off Elanco in IPO

Teva Just Can’t Seem to Get Earnings Right

Pfizer Gets the Script Flipped on It in Q2

What to Expect When Pfizer Reports Tuesday

Why Sienna Biopharmaceuticals Shares Are Stumbling

Why RedHill Is Monday’s Big Biopharma Winner

Why AbbVie Earnings Were Not Enough for Investors

Merck Underwhelms Despite Beating Earnings

Should Celgene Be Getting More Love?

Gilead Earnings Beat Not Enough For Investors

What to Expect When Gilead Reports

Major Pharma Stocks Scare Off Short Sellers

Major Biotechs See a Rising Tide of Short Interest

Does Biogen Deserve More Credit for Q2 Earnings?

Why Haliburton Is Monday’s Big Earnings Loser

What JEPQ Actually Paid the Last Time the Nasdaq Fell 10%: a Stress Test for Its 10% Yield

VOO Is About to Become the First $1 Trillion ETF, and SPY Holders Are Paying 3x More for the Same Index

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

Featured Reads

Laid Off at 58 With a 401(k) Loan, She Thought She Had 60 Days to Replace the Money. The Tax Code May Give Her Much Longer.

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later